FMP
SUPN icon

Financial Management Professionals’s Supernus Pharmaceuticals SUPN Stock Holding History

Financial Management Professionals’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-919
Closed -$29K – 1056
2025
Q2 		$29K Hold
919
– – ﹤0.01% 348
2025
Q1 		$30.1K Buy
+919
New +$32.6K ﹤0.01% 335

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Management Professionals's SUPN Position: Q3 2025 in Review

Financial Management Professionals sold out of Supernus Pharmaceuticals (SUPN) in Q3 2025, closing a stake of 919 shares — an estimated $29K sold.

Financial Management Professionals first reported a position in SUPN in Q1 2025 and held it in 2 quarters. The position peaked at $30.1K in Q1 2025. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Financial Management Professionals reported no remaining Supernus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Financial Management Professionals sold 919 Supernus Pharmaceuticals shares in Q3 2025, an estimated $29K.
  • Financial Management Professionals first reported a position in Supernus Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Financial Management Professionals's Supernus Pharmaceuticals position peaked at $30.1K in Q1 2025.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Financial Management Professionals's 13F filing for Q3 2025, filed 15 Oct 2025.